Table 3.
Univariate analysis | Multivariable analysis | ||||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
A: Chemotherapy plus immunotherapy regardless of RT (n = 705) | |||||
CTx plus immunotherapy | CTx and Immx within 30 days | Ref | Ref | ||
Immx 31–90 days before CTx | 1.179 (0.815–1.705) | 0.384 | 1.057 (0.716–1.561) | 0.781 | |
Immx 91–180 days before CTx | 0.901 (0.611–1.329) | 0.598 | 0.900 (0.584–1.388) | 0.635 | |
B: Only chemotherapy plus immunotherapy sample (n = 479) | |||||
CTx plus immunotherapy | CTx and immx within 30 days | Ref | Ref | ||
Immx 31–90 days before CTx | 1.166 (0.762–1.784) | 0.478 | 1.151 (0.731–1.812) | 0.544 | |
Immx 91–180 days before CTX | 0.984 (0.638–1.516) | 0.941 | 0.952 (0.595–1.523) | 0.838 | |
C: Chemoradiation plus immunotherapy sample (n = 226) | |||||
CTx plus immunotherapy | CTx and immx within 30 days | Ref | Ref | ||
Immx 31–90 days before CTx | 0.969 (0.455–2.065) | 0.936 | 0.860 (0.360–2.053) | 0.734 | |
Immx 91–180 days before CTX | 0.561 (0.228–1.377) | 0.207 | 0.549 (0.165–1.826) | 0.328 |
CTx, chemotherapy; Immx, immunotherapy; RTx, radiation therapy; Ref, reference.